E-LIB Suche - Ergebnisse für: Lazarovici, J.

1

Incidence, characteristics, management and outcome of patie..:

Gueiderikh, A. ; Ung, M. ; Lazarovici, J....
Cancer/Radiothérapie. 27 (2023) 5 - p. 370-375 , 2023

Link: https://doi.org/10.1016/..

2

EARLY FDG‐PET ADAPTED TREATMENT OF LIMITED STAGE HODGKIN LY..:

Federico, M. ; Fortpied, C. ; Stepanishyna, Y....
Hematological Oncology. 41 (2023) S2 - p. 159-160 , 2023

Link: https://doi.org/10.1002/..

3

MOLECULAR CHARACTERIZATION CONTRIBUTES TO DIAGNOSIS AND PRE..:

Camus, V. ; Viailly, P. ; Sesques, P....
Hematological Oncology. 41 (2023) S2 - p. 110-111 , 2023

Link: https://doi.org/10.1002/..

4

BRENTUXIMAB VEDOTIN AS CONSOLIDATION TREATMENT IN PATIENTS ..:

Gastinne, T. ; Bouabdallah, K. ; Moatti, H....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

5

OUTCOMES AFTER FIRST‐LINE IMMUNOCHEMOTHERAPY FOR PRIMARY ME..:

Camus, V. ; Rossi, C. ; Sesques, P....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

6

AMAHRELIS : ADCETRIS MAINTENANCE AFTER AUTOLOGOUS STEM CELL..:

Marouf, A. ; Cottereau, A. S. ; Kanoun, S....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

7

OUTCOME AND TREATMENT OF RELAPSING EARLY PET NEGATIVE PATIE..:

Gac, A. ; Chartier, L. ; Girinsky, T....
Hematological Oncology. 37 (2019) S2 - p. 294-296 , 2019

Link: https://doi.org/10.1002/..

8

FEASIBILITY AND BENEFIT OF MOLECULARLY‐INFORMED ENROLLMENT ..:

Michot, J. ; Camara‐Clayette, V. ; Detolle, A....
Hematological Oncology. 37 (2019) S2 - p. 330-331 , 2019

Link: https://doi.org/10.1002/..

9

Haematological immune-related adverse events with immune ch..:

Michot, J.M. ; Lazarovici, J. ; Tieu, A....
European Journal of Cancer. 122 (2019) - p. 72-90 , 2019

Link: https://doi.org/10.1016/..

10

EP-1249: Repeated low-dose radiation therapy in indolent No..:

Saleh, K. ; Michot, J.M. ; Schernberg, A....
Radiotherapy and Oncology. 127 (2018) - p. S690 , 2018

Link: https://doi.org/10.1016/..

11

EZH2 alterations in follicular lymphoma: biological and cli..:

Huet, S ; Xerri, L ; Tesson, B...
Blood Cancer Journal. 7 (2017) 4 - p. e555-e555 , 2017

Link: https://doi.org/10.1038/..

12

Long-Term Outcomes in Patients With Solitary Bone Plasmacyt..:

Bacorro, W. ; Schernberg, A. ; Lazarovici, J....
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. E426-E427 , 2017

Link: https://doi.org/10.1016/..

13

PV-0044: Is involved-node radiotherapy for Hodgkin lymphoma..:

Boros, A. ; Sun, R. ; Arfi Rouche, J....
Radiotherapy and Oncology. 123 (2017) - p. S19 , 2017

Link: https://doi.org/10.1016/..

14

Use of 5-azacitidine for therapy-related myeloid neoplasms ..:

Annereau, M. ; Willekens, C. ; El Halabi, L....
Leukemia Research. 55 (2017) - p. 58-64 , 2017

Link: https://doi.org/10.1016/..

15

Molecular landscape of relapse/refractory diffuse large B‐c..:

Michot, J. ; Camara‐Clayette, V. ; Chahine, C....
Hematological Oncology. 35 (2017) S2 - p. 279-280 , 2017

Link: https://doi.org/10.1002/..